Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada

Authors: Richard Musto, Jodi E Siever, J Cyne Johnston, Judy Seidel, M Sarah Rose, Deborah A McNeil

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

The Alberta Immunization Program offers a vaccine against the Human Papillomavirus (HPV) free of charge to all girls in Grades 5 and 9. The vaccine is provided in two different service delivery models depending upon the acceptance of the program by the local school board. Vaccinations may be provided “in-school” or in “community” through appointments at Public Health Clinics. The purpose of this study was to determine whether there was a difference in vaccine uptake in Calgary between the two service delivery models, “in-school” and “community”, and to examine if socioeconomic status (SES) was a contributing factor.

Methods

Individual data from the Calgary Zone Public Health vaccination database for all grade 5 and 9 girls in Calgary for school years 2008–2011 were analyzed using descriptive statistics. These data included vaccination records for 35,592 girls. Logistic regression was used to examine the effect of delivery system and SES status on being vaccinated, controlling for school type.

Results

HPV vaccination completion rates were 75% (95% confidence interval = 74.7%, 75.8%) for girls with an “in-school” compared to 36% (95% confidence interval = 35.3%, 37.2%) for girls in schools with a “community” service delivery model. A girl’s neighbourhood SES was related to the likelihood of being HPV vaccinated depending on the service delivery model available to her. For girls attending a Public school with an “in-school” delivery model, the proportion completing vaccination increased as SES decreased (high SES = 79%; medium SES = 79%; low SES = 83%; p-value<0.001). For girls attending Calgary Catholic School District schools with the “community” delivery model there was a decrease in immunization rates from high and mid to low SES (high SES = 41%; medium SES = 42%; low SES = 34%; p-value<0.001). These results show that those with lower SES were differentially disadvantaged by not having access to an “in-school” vaccination delivery model.

Conclusion

Service delivery models make a difference in HPV vaccination completion rates and create inequities for health protection and disease prevention based on socioeconomic status.
Appendix
Available only for authorised users
Literature
3.
go back to reference Pampalon R, Hamel D, Gamache P, Raymond G: A deprivation index for health planning in Canada. Chronic Dis Can. 2009, 29: 178-91.PubMed Pampalon R, Hamel D, Gamache P, Raymond G: A deprivation index for health planning in Canada. Chronic Dis Can. 2009, 29: 178-91.PubMed
4.
go back to reference StataCorp: Stata Statistical Software: Release 12. 2011, College Station, TX: StataCorp LP StataCorp: Stata Statistical Software: Release 12. 2011, College Station, TX: StataCorp LP
5.
go back to reference Collet D: Modelling survival data in medical research. 2003, London: Chapman and Hall, 80-81. 2 Collet D: Modelling survival data in medical research. 2003, London: Chapman and Hall, 80-81. 2
6.
go back to reference Smith LM, Brassard P, Kwong JC, Deeks SL, Ellis AK, Levesque LE: Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of Grade 8 girls. BMC Publ Health. 2011, 11: 645-10.1186/1471-2458-11-645.CrossRef Smith LM, Brassard P, Kwong JC, Deeks SL, Ellis AK, Levesque LE: Factors associated with initiation and completion of the quadrivalent human papillomavirus vaccine series in an Ontario cohort of Grade 8 girls. BMC Publ Health. 2011, 11: 645-10.1186/1471-2458-11-645.CrossRef
7.
go back to reference Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS: Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009, 69: 475-80. 10.1016/j.socscimed.2009.05.024.CrossRefPubMed Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS: Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009, 69: 475-80. 10.1016/j.socscimed.2009.05.024.CrossRefPubMed
10.
go back to reference Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, et al: A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: Parental factors associated with HPV vaccine receipt. PLoS Med. 2010, 7: e1000270-10.1371/journal.pmed.1000270.CrossRefPubMedPubMedCentral Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, et al: A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: Parental factors associated with HPV vaccine receipt. PLoS Med. 2010, 7: e1000270-10.1371/journal.pmed.1000270.CrossRefPubMedPubMedCentral
11.
go back to reference Constantine NA, Jerman P: Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. J Adolesc Health. 2007, 40: 108-15. 10.1016/j.jadohealth.2006.10.007.CrossRefPubMed Constantine NA, Jerman P: Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. J Adolesc Health. 2007, 40: 108-15. 10.1016/j.jadohealth.2006.10.007.CrossRefPubMed
12.
go back to reference Marlow LAV, Waller J, Wardle J: Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007, 25: 1945-52. 10.1016/j.vaccine.2007.01.059.CrossRefPubMed Marlow LAV, Waller J, Wardle J: Parental attitudes to pre-pubertal HPV vaccination. Vaccine. 2007, 25: 1945-52. 10.1016/j.vaccine.2007.01.059.CrossRefPubMed
13.
go back to reference Brewer NT, Fazekas KI: Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med. 2007, 45: 107-14. 10.1016/j.ypmed.2007.05.013.CrossRefPubMed Brewer NT, Fazekas KI: Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med. 2007, 45: 107-14. 10.1016/j.ypmed.2007.05.013.CrossRefPubMed
14.
go back to reference Castellsague X, Schneider A, Kaufmann AM, Bosch FX: HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol. 2009, 115: S15-23. 10.1016/j.ygyno.2009.09.021.CrossRefPubMed Castellsague X, Schneider A, Kaufmann AM, Bosch FX: HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol. 2009, 115: S15-23. 10.1016/j.ygyno.2009.09.021.CrossRefPubMed
15.
go back to reference Friesen B: Health of the Region: Report of the Medical Officer of Health. 2006, Calgary Health Region Friesen B: Health of the Region: Report of the Medical Officer of Health. 2006, Calgary Health Region
Metadata
Title
Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada
Authors
Richard Musto
Jodi E Siever
J Cyne Johnston
Judy Seidel
M Sarah Rose
Deborah A McNeil
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-640

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue